SPECTRUM AND OUTCOME OF CONGESTIVE-HEART-FAILURE IN A HOSPITALIZED POPULATION

被引:88
|
作者
ANDERSSON, B
WAAGSTEIN, F
机构
[1] Wallenberg Laboratory of Cardiovascular Research, Division of Cardiology, Sahlgrenska Sjukhuset, Göteborg
关键词
D O I
10.1016/0002-8703(93)90414-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
There are very few contemporary studies on the frequency and cause of congestive heart failure (CHF) in a general population. In western Sweden, inhabited by 1.64 million people, a retrospective survey was performed. All hospital records of patients with CHF, ages 16 through 65 years, were examined in all hospitals in the region. During the study period 2711 patients fulfilled the criteria for CHF or cardiomyopathy. Patients were monitored for 37 +/- 28 months. The most common cause of heart failure was coronary artery disease (IHD) (40%). Other common causes were hypertension (17%), valvular disease (13%), alcohol (11%), diabetes mellitus (10%), and systemic diseases (10%). There were positive correlations between the male sex and IHD, alcohol, and dilated cardiomyopathy; the female sex was associated with systemic diseases, valvular heart disease, and diabetes. The incidence of CHF requiring hospitalization per 100,000 in the population was 1.2 to 263 men and 1.1 to 129 women, in the youngest (age 16 to 30 years) and oldest (61 to 65 years) age groups, respectively. The 5-year survival rate was 50%. Analysis of causes performed with Cox's proportional hazards model for survival showed that age, IHD, alcohol, and diabetes were independent and powerful predictors of mortality (p < 0.001). The mode of death was progressive heart failure in 54% and sudden death in 26%. We concluded that the prognosis in patients with CHF was still very poor, even among this young population. The most common cause of CHF was IHD, and the second was hypertension.
引用
收藏
页码:632 / 640
页数:9
相关论文
共 50 条
  • [1] THE SPECTRUM AND OUTCOME OF CONGESTIVE-HEART-FAILURE IN A HOSPITALIZED POPULATION
    ANDERSSON, B
    WAAGSTEIN, F
    CIRCULATION, 1993, 88 (04) : 358 - 358
  • [2] A TRIAGE GUIDELINE FOR PATIENTS HOSPITALIZED WITH CONGESTIVE-HEART-FAILURE
    WEINGARTEN, SR
    RIEDINGER, MS
    SHINBANE, JS
    SIEGEL, RJ
    CONNER, L
    PRECHTL, K
    ELLRODT, AG
    CLINICAL RESEARCH, 1993, 41 (02): : A552 - A552
  • [3] Spectrum of risk factors and comorbidity in a hospitalized population with congestive heart failure
    Martínez-Sellés, M
    Robles, JAG
    Prieto, L
    Serrano, JA
    Muñoz, R
    Frades, E
    Almendral, J
    EUROPEAN HEART JOURNAL, 2002, 23 : 88 - 88
  • [4] CONGESTIVE-HEART-FAILURE
    LEWANDOWSKI, DM
    AMERICAN JOURNAL OF NURSING, 1995, 95 (05) : 36 - 37
  • [5] CONGESTIVE-HEART-FAILURE
    KATS, BA
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 268 (06): : 738 - 738
  • [6] CONGESTIVE-HEART-FAILURE
    WERKO, L
    ACTA MEDICA SCANDINAVICA, 1987, 221 (01): : 3 - 14
  • [7] THE PHARMACOKINETICS OF ENALAPRIL IN HOSPITALIZED-PATIENTS WITH CONGESTIVE-HEART-FAILURE
    DICKSTEIN, K
    TILL, AE
    AARSLAND, T
    TJELTA, K
    ABRAHAMSEN, AM
    KRISTIANSON, K
    GOMEZ, HJ
    GREGG, H
    HICHENS, M
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 23 (04) : 403 - 410
  • [8] CONGESTIVE-HEART-FAILURE
    RUGGIE, N
    MEDICAL CLINICS OF NORTH AMERICA, 1986, 70 (04) : 829 - 851
  • [9] CONGESTIVE-HEART-FAILURE
    SREBRO, JP
    KARLINER, JS
    CURRENT PROBLEMS IN CARDIOLOGY, 1986, 11 (06) : 305 - 365
  • [10] READMISSION RATES FOR CONGESTIVE-HEART-FAILURE IN THE MEDICARE POPULATION
    KRUMHOLZ, HM
    HENNEN, J
    RADFORD, MJ
    WANG, Y
    MEEHAN, TP
    CIRCULATION, 1994, 90 (04) : 43 - 43